Reckitt Benckiser shines again as results beat forecast

Sales in the second quarter in Europe had disappointed the market, the last time that the company reported numbers in July. However third quarter before the profit 21pc Reckitt pink 568 m £, and 7pc sales climbed to the exclusion of the oscillations of the currency.

Profit margin, which rose by 2.2 percentage points, both beat forecasts and shares have increased as much as 121 p, to close up to 32% to £ 35.57.

For the year 2010, full Strepsils throat candy manufacturer and Cillit Bang, cleansing products expected sales increase 6pc and a net profit of enterprise montée.Résultats 16pc will get extra boost of the acquisition of SSL, which makes Durex condoms and footwear Scholl.Le redemption of. 54bn £ 2 has been agreed in July and completed earlier this week.

"The third quarter of the report confirms our thesis Reckitt Benckiser continues to be a well-managed company, despite the pressures of the market," said analysts Sanford c. Bernstein.

Sales increased 18pc 481 m £ business on Reckitt developing markets, which includes Asia and South America, the third trimestre.Désodorisant Airwick and Strepsils have been among the best-selling products.Operating profits jumped 28pc 68 million from £.

In Europe, which remains the largest market for Reckitt sales, third quarter sales were flat 843 m £, with the benefit of 196 million to £ operating.Sales visibility, powder coating and washing water softeners suffered because of the low consumption in the region.

Health, personal care and air fresheners were two powerful divisions of Reckitt, with sales increasing 7pc in deux.Après purchase SSL, Reckitt get about a third of its revenue comes from the fast-growing health and personal care category, compared to rival maintenant.Unilever 27pc also expands its activities in this area.

Third quarter results of the Reckitt received his heroin replacement drug Suboxone, sales of which rose 27pc 505 million boost from £ .the drug has lost its patent United States, but no less expensive generic competitor has yet been jour.à excluding pharmaceuticals company, Reckitt expects sales 5MC 10pc increase in operating income increased this year.

The last month of Reckitt separated with its Director of finance for ten years, Colin Day and is looking for its replacement.


View the original article here

You can leave a response, or trackback from your own site.

0 Response to "Reckitt Benckiser shines again as results beat forecast"

Post a Comment

Powered by Blogger